STAT+: In wake of boy’s death, gene editing experts dissect Huidagene’s decisions
Experts question technical improvements Huidagene tried when using a Duchenne muscular dystrophy treatment strategy largely abandoned by U.S. companies.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.